TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Motor evoked potential amplitude of target muscle (wrist flexor)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area Under the Curve From Time 0 to Last Quantifiable Concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve From Time 0 to Extrapolated Infinite Time (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Guideline concordant breast cancer treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Hepatic Steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Change in Hepatic Inflammation/Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Postoperative Pain During PACU Admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Pain During Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of stenosis assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of stenosis assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of stenosis assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in LSAS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: BOLD response in key brain areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety and tolerability of multiple doses
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction on postoperative morphine consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Utilization of features promoted by reminders
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: EEG/ERP recordings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients with inadequate oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of patients achieving 5% reduction from Baseline Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: In-hospital SIRS-based mortality
Endpoint domain: Mortality/survival
Primary endpoint: Delay to disability deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of Hypnotic Discontinuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area Under the Plasma Concentration-time Curve from Time 0 to Time 24 Hours (AUC0-24h) for Tacrolimus (Part A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Adverse Events (Part A + B)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Adverse Events (Part C)
Endpoint domain: Adverse events/effects
Primary endpoint: disability measurement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Child Sleep Duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Incidence of chronic hemodialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Overall assessment score: Pre
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall assessment score: Post
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effective time of ideal posturing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV transcription levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right ventricle failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants with Dose-Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum-Tolerated Dose (MTD) of RO6958688
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recommended Phase II Dose (RP2D) of RO6958688
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Neuropsychiatric Inventory Questionnaire Average Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Delivery week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Child's weight at birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Apgar score 5 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Validation of extra cochlear electrodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio to Baseline of Epithelial Cell Proliferation as Assessed by Ki67 Staining of Buccal Mucosal Tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Grade 2 or Higher Specific Skin-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Ratio to Baseline of Amylase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving virologic success at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving virologic success at end of TLD and RIF-Containing TB Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sound Processing parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTX-I Bone Turnover Marker Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PINP Bone Turnover Marker Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Subjects With Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Medically Attended Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Experienced at Least 1 Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage Change From Baseline to Day 28 in Pulmonary Vascular Resistance (PVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Graft failure or rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma PK profile of lorcaserin and its primary metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference of Binding Potentials of 18F-PSS232
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Microbiologic evidence of infection
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of dementia
Endpoint domain: Mortality/survival
Primary endpoint: Improvement of OCD symptoms on YBOCS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedure failure of ultrasound
Endpoint domain: Adverse events/effects
Primary endpoint: Children Fear Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pregnancy-specific topic/guideline adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time point of clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of H. pylori
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Detection of clarithromycin resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cumulative Live Birth Rate
Endpoint domain: Mortality/survival
Primary endpoint: Blood Perfusion Index delta
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in G-Score from GRBAS-Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Average pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Direct Hospital Cost
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change of pain from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: combined allergy symptom + medication scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of change in implant stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients With at Least Minimal Improvement in CGI-C Rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Modified Oswestry Low Back Pain Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Numeric Pain Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Postoperative Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Binge Eating Episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to tolerate Ischaemic Preconditioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive cultures of collected specimens
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of reverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Maternal systemic marker of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maternal systemic marker of oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to first-line therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of surgical referral
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients who undergo surgery of the primary tumor
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: serum level of sTREM-1 (ng/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum level of sUPAR (ng/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum level of CRP (mg/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Non-acute Emergency Department Visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Preoperative HbA1c level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum Walking Distances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: angina event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Eyelash length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pupil Responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percent of Self-Test Fingerstick Blood Glucose Results within specified limits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Painscore during mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urea removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Sensitisation to electrical stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Delirium measured by geriatricians using DSM-IV criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Delirium measured by geriatricians using DSM-5 criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Delirium measured by advanced practice nurses using the mCAM-ED
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: subjective stress level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AOFAS scoring system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Developed Infective Endocarditis
Endpoint domain: Adverse events/effects
Primary endpoint: Fluid removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival with Cerebral Performance Category 1 or 2
Endpoint domain: Mortality/survival
Primary endpoint: Physicians Global Assessment to measure quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Positive blood Cultures
Endpoint domain: Adverse events/effects
Primary endpoint: Early change in circulating tumor-derived DNA (ctDNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants in Complete Remission 6 Months After Randomization
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Severe Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: recurrence of major depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elevation in intracranial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: First occurrence of hospitalized angioneurotic oedema
Endpoint domain: Adverse events/effects
Primary endpoint: First occurrence of pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: First occurrence of gastroenteritis
Endpoint domain: Adverse events/effects
Primary endpoint: First occurrence of failure to thrive
Endpoint domain: Adverse events/effects
Primary endpoint: First occurrence of convulsions/seizures
Endpoint domain: Adverse events/effects
Primary endpoint: First occurrence of acute interstitial nephritis
Endpoint domain: Adverse events/effects
Primary endpoint: First occurrence of thrombocytopenia
Endpoint domain: Adverse events/effects
Primary endpoint: Leiden Surgical Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of RAS mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of geriatric syndromes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant adherence to study protocols
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction of venous Fasting Plasma Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intolerance to carotid clamping test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total estimated blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Vascularity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Efficacy of Oral Versus Intravenous Ibuprofen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Oral Versus Intravenous Ibuprofen
Endpoint domain: Adverse events/effects
Primary endpoint: Cough severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients with objective manifestations of Lyme borreliosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of nonspecific symptoms such as headache, fatigue, arthralgia, myalgia
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Caspofungin plasma concentrations (AUC, peak level, trough concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Cortical to Cerebellum SUVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Peak Knee Flexion During Swing Phase of Gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of acute myocardial events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Identification of regions of copy number abnormalities (CNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Identification of uniparental disomy in leukemic lymphoblasts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gene expression profiles for leukemic lymphoblasts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of FK506 combined with MMF versus intravenous CTX pulses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve From Time Zero to Time Tlast (AUC[0-tlast])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social Autonomy
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Efficacy in inducing mucosal healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: coagulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: SABR-related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: No live lice eggs and/or live lice
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Skin irritancy or sensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Visual field size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Survived event
Endpoint domain: Mortality/survival
Primary endpoint: Pelvic Girdle Pain Questionnaire (PGPQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Score of evaluation of motion sickness susceptibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of equilibrium evaluated with posturographic test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Orthostatic Symptom Burden
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical response of HFNC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: altered Th2, Th9, and Th17 differentiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Volume Voided (MVV) Per Micturition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in number of transient lower esophageal sphincter relaxations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Gastric Emptying Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Small Bowel Transit Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Colon Transit Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Whole Gut Transit Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of patients on target International Normalized Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Stabilization of International Normalized Ratio during follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: satisfaction of patient and treating doctor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ultrasound examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Colonoscopy examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With Serious AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With AEs Leading to Study Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Identification of patients with suboptimal debulking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events and serious adverse events (AEs & SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Urinalysis, hematology & biochemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual Urine Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Decrease in pro-inflammatory cytokine production (TNF-alpha)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in muscle protein breakdown
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: GBS colonization levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: change in biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success Rate of Surgery Without Additional Anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: HER2-expression measured by 68Ga-ABY-025 PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes